Intravascular Catheters Market Size, Share & Trends Analysis Report and Segment Forecast, 2025| Grand View Research, Inc
“The global intravascular catheters market size was valued at USD 4.1 billion in 2018 and is anticipated to grow at a lucrative rate over the forecast period.”
The global Intravascular Catheters Market size is expected to reach USD 8.8 billion by 2025, according to a new report by Grand View Research, Inc., registering an 11.8% CAGR during the forecast period. Increasing number of surgical procedures requiring catheters, growing awareness about hospital-acquired infections, and increasing coverage of healthcare insurance are some of the factors contributing to the demand for intravascular catheters from 2019 to 2025. The market is also expected to be driven by increasing number of patients undergoing cardiovascular as well as urological procedures and rising incidents of trauma injuries. Short Peripheral Intravascular Catheters (PIVC) dominated the market with a revenue of USD 2.8 billion in 2018, on account of lower infection risk associated with these products. In addition, short PIVCs are preferred over other catheters due to their quick discharge and short dwelling time. This product segment is expected to witness lucrative CAGR between 2018 to 2025 as a consequence of increasing concerns over catheterassociated bloodstream infections leading to catheter colonization. Hospitals dominated the market on the basis of end use in 2018, with a revenue of USD 2.5 billion. The trend is likely to continue over the forecast period owing to increase in number of surgical procedures requiring catheters, growing health insurance coverage, and rising hospital admissions. Ambulatory Surgical Centers
Follow Us:
(ASC) are anticipated to witness the fastest growth, with a CAGR of 13.5% through 2025. Surgical procedures are cheaper in ASCs as compared to hospitals. As a result, the market is expected to witness a rise in adoption of surgical procedures in ASCs, which in turn is anticipated to drive demand for intravascular catheters over the forecast period. Asia Pacific dominated the intravascular catheters market with a revenue of USD 1.2 billion in 2018, owing to high patient base, increasing investments in healthcare infrastructure, growing insurance coverage, and availability of reimbursements. This region is anticipated to witness lucrative growth due to its high potential in overcoming unmet medical needs among patients suffering from cardiovascular and urological diseases as well as trauma injuries. China dominated the APAC market with a 23.3% revenue share in 2018 owing to high unmet medical needs, growing awareness about hospital-acquired infections, and increase in healthcare accessibility. Thus, a high population base with unmet medical needs is expected to drive demand for intravascular catheters between 2018 to 2025. To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/intravascular-catheters-market Further key findings from the report suggest:
Asia Pacific dominated the market in 2018 with a revenue of USD 1.2 billion, owing to factors such as large patient base, growing awareness regarding hospital-acquired infections, increase in healthcare access, and expanding healthcare coverage
U.S. is the largest country with an incremental opportunity of USD 542.0 million from 2019 to 2025
The hospitals segment dominated the market by end use in 2018 owing to growing number of surgical procedures requiring intravascular catheters and increasing hospital admissions
Some of the key players in this market are Boston Scientific Corporation; C.R. Bard, Inc.; Johnson & Johnson Services, Inc.; Abbott; Coloplast Ltd; Smith Medical; Edwards Lifesciences Corporation; Medtronic; McKesson Medical Surgical Inc.; and TERUMO CORPORATION.
Grand View Research has segmented the global intravascular catheters market on the basis of product, application, end use, and region:
Follow Us:
Intravascular Catheters Product Outlook (Revenue, USD Million, 2014 - 2025)
Short PIVC
Integrated/Closed PIVC
Intravascular Catheters Application Outlook (Revenue, USD Million, 2014 - 2025)
Oncology
Gastroenterology
Renal Disease
Infectious Diseases
Others
Intravascular Catheters End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Clinics
ASC
Homecare
Others
Intravascular Catheters Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America o
U.S.
o
Canada
Europe
Follow Us:
o
Germany
o
U.K.
o
Spain
o
France
o
Italy
o
Russia
Asia Pacific o
Japan
o
China
o
India
o
South Korea
o
Singapore
o
Australia
Latin America o
Mexico
o
Brazil
o
Argentina
MEA
Follow Us:
o
South Africa
o
Saudi Arabia
o
UAE
Table of Content of Intravascular Catheters Market Chapter 1 Methodology and Scope 1.1 Market Segmentation & Scope 1.2 Market Definition 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2 GVR’s Internal Database 1.3.3 Secondary Sources & Third Party perspectives 1.3.4 Primary Research 1.4 Information Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Data Visualization 1.6 Data Validation & Publishing Chapter 2 Executive Summary 2.1 Intravascular Catheters Market Outlook, By Revenue (USD Million) 2.2 Intravascular Catheters Market Segment Outlook, By Revenue (USD Million) 2.3 Competititve Insights Chapter 3 Intravascular Catheters Market Variables, Trends and Scope 3.1 Market Lineage Outlook 3.1.1 Market Outlook 3.2 Penetration & Growth Prospect Mapping 3.3 Product Pipeline Analysis, by Stage 3.4 Industry Value Chain Analysis 3.4.1 User Perspective Analysis 3.4.1.1 Consumer Behaviour Analysis 3.4.1.2 Market Influencer Analysis 3.4.2 Intravascular Catheters Cost Structure Analysis 3.4.3 List of Key End-users, By Region/By Product/By Country 3.5 Technology Overview 3.5.1 Technology Timeline
Follow Us:
3.6 Regulatory Framework 3.6.1 Reimbursement Framework 3.6.2 Standards & Compliances 3.7 Market Dynamics 3.7.1 Market Driver Analysis 3.7.1.1 Increasing Prevalance of Cardiovascular Diseases 3.7.1.2 Increasing Prevalence of Diabetes 3.7.1.3 Increasing Prevalence of End Stage Renal Disease (ESRD) 3.7.2 Market Restraint Analysis 3.7.2.1 Low Penetration of Reimbursement and High Percentage of Out-of-pocket Expenditure in Emerging Markets 3.7.3 Industry Challenges 3.8 Intravascular Catheters Market Analysis Tools 3.8.1 Industry Analysis - Porter's 3.8.1.1 Supplier Power 3.8.1.2 Buyer Power 3.8.1.3 Substitution Threat 3.8.1.4 New Entrants Threat 3.8.1.5 Competitive Rivalry 3.8.2 PESTEL Analysis 3.8.2.1 Political Landscape 3.8.2.2 Economic Landscape 3.8.2.3 Social Landscape 3.8.2.4 Technology Landscape 3.8.3 Major Deals and Strategic Alliances Analysis 3.8.4 Market Entry Strategies 3.8.5 Case Studies Chapter 4 Intravascular Catheters Market - Competitive Analysis 4.1 Recent Developments & Impact Analysis, by Key Market Participants 4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players) 4.3 Public Companies
Follow Us:
4.3.1 Company Market Position Analysis 4.3.2 Company Market Share/Region, by Region 4.4 Private Companies 4.4.1 List of Key Emerging Companies/Technology Disruptors/Innovators 4.4.2 Regional Network Map 4.4.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience) 4.5.4 Supplier Ranking Chapter 5 Intravascular Catheters Market: Product Estimates & Trend Analysis 5.1 Definitions & Scope 5.2 Intravascular Catheters Market Share by Product, 2018 & 2025 5.3 Segment Dashboard 5.4 Short PIVC catheters 5.4.1 Short PIVC catheters market estimates and forecasts, 2014 - 2025 (USD Million) 5.4.2 Short PIVC catheters market estimates and forecasts, by application, 2014 - 2025 (USD Million) 5.5 Integrated/Closed PIVC catheters 5.5.1 Integrated/Closed PIVC catheters market estimates and forecasts, 2014 - 2025 (USD Million) 5.5.2 Integrated/Closed PIVC catheters market estimates and forecasts, by application, 2014 - 2025 (USD Million) Chapter 6 Intravascular Catheters Market: Application Estimates & Trend Analysis 6.1 Definitions & Scope 6.2 Intravascular Catheters Market Share by Product, 2018 & 2025 6.3 Segment Dashboard 6.4 Oncology 6.4.1 Oncology market estimates and forecasts, 2014 - 2025 (USD Million) 6.5 Gastroenterology 6.5.1 Gastroenterology market estimates and forecasts, 2014 - 2025 (USD Million) 6.6 Renal Disease 6.6.1 Renal Disease Market Estimates And Forecasts, 2014 - 2025 (USD Million) 6.7 Infectious Diseases 6.7.1 Infectious Diseases Market Estimates And Forecasts, 2014 - 2025 (USD Million)
Follow Us:
6.8 Other Diseases 6.8.1 Other Diseases Market Estimates And Forecasts, 2014 - 2025 (USD Million) Chapter 7 Intravascular Catheters Market: End Use Estimates & Trend Analysis 7.1 Definitions & Scope 7.2 Intravascular Catheters Market Share by Raw Materials, 2018 & 2025 7.3 Segment Dashboard 7.4 Hospitals 7.4.1 Hospitals Market Estimates And Forecasts, 2014 - 2025 (USD Million) 7.5 Clinics 7.5.1 Clinics Market Estimates And Forecasts, 2014 - 2025 (USD Million) 7.6 ASC 7.6.1 ASC Market Estimates And Forecasts, 2014 - 2025 (USD Million) 7.7 Homecare 7.7.1 Homecare Market Estimates And Forecasts, 2014- 2025 (USD Million) 7.8 Others 7.8.1 Others Market Estimates And Forecasts, 2014- 2025 (USD Million) Chapter 8 Intravascular Catheters Market: Regional Estimates & Trend Analysis, by Product 8.1 Regional Market Snapshot 8.2 Regional Market Share and Leading Players, 2018 8.2.1 North America 8.2.2 Europe 8.2.3 Asia Pacific 8.2.4 Latin America 8.2.5 Middle East & Africa 8.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 8.3.1 North America 8.3.2 Europe 8.3.3 Asia Pacifc 8.3.4 Latin America 8.4.5 Middle East & Africa 8.4 Intravascular Catheters Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
Follow Us:
8.4.1 North America 8.4.1.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.1.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.1.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.1.4 U.S. 8.4.1.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.1.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.1.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.1.5 Canada 8.4.1.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.1.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.1.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2 Europe 8.4.2.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.4 U.K. 8.4.2.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.5 Germany 8.4.2.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.6 Spain 8.4.2.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.6.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.7 France 8.4.2.7.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.7.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million)
Follow Us:
8.4.2.7.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.8 Italy 8.4.2.8.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.8.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.8.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.2.9 Russia 8.4.2.9.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.2.9.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.2.9.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3 Asia Pacific 8.4.3.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.4 China 8.4.3.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.5 Japan 8.4.3.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.6 India 8.4.3.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.6.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.7 South Korea 8.4.3.7.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.7.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.7.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.8 Singapore 8.4.3.8.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million)
Follow Us:
8.4.3.8.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.8.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.3.9 Australia 8.4.3.9.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.3.9.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.3.9.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.4 Latin America 8.4.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.4.4 Brazil 8.4.4.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.4.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.4.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.4.5 Mexico 8.4.4.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.4.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.4.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.4.6 Argentina 8.4.4.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.4.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.4.6.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.5 Middle East & Africa (MEA) 8.4.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.5.4 South Africa 8.4.5.4.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.5.4.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.5.4.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.5.5 Saudi Arabia
Follow Us:
8.4.5.5.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.5.5.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.5.5.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) 8.4.5.6 UAE 8.4.5.6.1 Market estimates and forecasts, by product 2014 - 2025 (USD Million) 8.4.5.6.2 Market estimates and forecasts, by end use 2014 - 2025 (USD Million) 8.4.5.6.3 Market estimates and forecasts, by application 2014 - 2025 (USD Million) Chapter 9 Competitive Landscape 9.1 Company Profiles 9.1.1 C.R. Bard, Inc. 9.1.1.1 Company Overview 9.1.1.2 Financial Performance 9.1.1.3 Product Benchmarking 9.1.1.4 Strategic Initiatives 9.1.2 Coloplast 9.1.2.1 Company Overview 9.1.2.2 Financial Performance 9.1.2.3 Product Benchmarking 9.1.2.4 Strategic Initiatives 9.1.3 Getinge AB 9.1.3.1 Company Overview 9.1.3.2 Financial Performance 9.1.3.3 Product Benchmarking 9.1.3.4 Strategic Initiatives 9.1.4 Boston Scientific Corporation 9.1.4.1 Company Overview 9.1.4.2 Financial Performance 9.1.4.3 Product Benchmarking 9.1.4.4 Strategic Initiatives 9.1.5 Johnson & Johnson 9.1.5.1 Company Overview
Follow Us:
9.1.5.2 Financial Performance 9.1.5.3 Product Benchmarking 9.1.5.4 Strategic Initiatives 9.1.6 Smiths Medical 9.1.6.1 Company Overview 9.1.6.2 Financial Performance 9.1.6.3 Product Benchmarking 9.1.6.4 Strategic Initiatives 9.1.7 Edwards Life Sciences Corporation 9.1.7.1 Company Overview 9.1.7.2 Financial Performance 9.1.7.3 Product Benchmarking 9.1.7.4 Strategic Initiatives 9.1.8 Medtronic, Inc. 9.1.8.1 Company Overview 9.1.8.2 Financial Performance 9.1.8.3 Product Benchmarking 9.1.8.4 Strategic Initiatives 9.1.9 Cook Medical 9.1.9.1 Company Overview 9.1.9.2 Financial Performance 9.1.9.3 Product Benchmarking 9.1.9.4 Strategic Initiatives 9.1.10 McKesson Medical Surgical Inc. 9.1.10.1 Company Overview 9.1.10.2 Financial Performance 9.1.10.3 Product Benchmarking 9.1.10.4 Strategic Initiatives 9.1.11 TERUMO CORPORATION 9.1.11.1 Company Overview 9.1.11.2 Financial Performance
Follow Us:
9.1.11.3 Product Benchmarking 9.1.11.4 Strategic Initiatives 9.2 List of Other Companies
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc
Follow Us:
Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:
[email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:
